Health & Medicine
- Health & Medicine
Cancer drug limits MS relapses
The anticancer drug retuximab inhibits nerve damage and relapses in multiple sclerosis patients.
- Health & Medicine
Drug Running: Bust nets suspects in counterfeit antimalaria trade
Investigators have traced the source of counterfeit antimalarial pills in Southeast Asia to southern China, where suspects have been arrested and an illicit factory shut down.
- Health & Medicine
Caffeine intake tied to miscarriage
Intake of caffeine equal to two cups of coffee per day seems to double a woman's risk of miscarriage.
- Health & Medicine
Weighty Evidence
Connections between the family of insulin hormones and cancer have been suspected for more than 2 decades, and today, drug companies are testing anticancer drugs based on the actions of an insulin cousin.
- Health & Medicine
Pot Downer: Marijuana users risk gum disease
Regular marijuana smoking is linked to gum disease in young adults.
- Health & Medicine
Warning Sign: Genetic fragments tag cancer severity
High levels of the microRNA miR-21 lead to poor prognoses for colon cancer patients.
-
- Health & Medicine
New route to insulin-making cells
Researchers have found cells resembling stem cells in the mouse pancreas, suggesting new ways to treat diabetes.
- Health & Medicine
Receptor may be cancer accomplice
Suppressing a receptor protein called neuropilin-2 slows colon cancer growth in mice.
- Health & Medicine
Bariatric Reversal: Stomach surgery curbs some patients’ diabetes
Weight-loss stomach surgery in obese people with type 2 diabetes sends the disease into remission in some patients.
- Health & Medicine
Phoenix Heart: Replacing a heart’s cells could ease transplants
Scientists removed all the cells from a dead rat heart, injected new heart cells, and produced a beating heart, paving the way for eventually growing organs for transplantation in humans.
- Health & Medicine
Getting the Red Out: Drug improves kids’ psoriasis symptoms
The rheumatoid arthritis drug etanercept clears up psoriasis in children and may become the first systemic medication for the ailment in youngsters.
